ATF3 and atherosclerosis: In the present study, miR-486 was predicted to target ATF3, which plays complex roles in cardiovascular pathogenesis (e.g., atherosclerosis, hypertrophy) and protection, underscoring its involvement in cardiac adaptation and stress responses [37].